1 The effectiveness of teriparatide in the clinical practice-attenuation of the bone mineral density outcome by increasing age and bisphosphonate pretreatment Annals of Medicine, May 22, 2013 Evidence Based Medicine
2 Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial The Lancet Oncology, June 11, 2013
3 High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma Cancer, May 22, 2013
4 Selective transurethral resection of the prostate combined with transurethral incision of the bladder neck for bladder outlet obstruction in patients with small volume benign prostate hyperplasia (BPH): a prospective randomized study PLOS ONE, May 20, 2013
5 A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: Results of a randomized, controlled, multicenter trial Cancer, June 14, 2013
6 Type II diabetes and metabolic syndrome in relation to head and neck squamous cell carcinoma risk: A SEER-Medicare database study Cancer Epidemiology, June 17, 2013
7 A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults Journal of Clinical Endocrinology and Metabolism, June 5, 2013 Review Article
8 Level IIB lymph node metastasis in oropharyngeal squamous cell carcinoma The Laryngoscope, May 21, 2013
9 Primary Thyroid Lymphoma: A Clinical Review Journal of Clinical Endocrinology and Metabolism, May 29, 2013 Review Article
10 Conservative management of thyroglobulin-positive, nonlocalizable thyroid carcinoma Head & Neck, June 5, 2013 Review Article
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor